Search Result "eprotirome"
Lipoprotein(a): Medical Treatment Options for an Elusive Molecule
Journal: Current Pharmaceutical Design
Volume: 17 Issue: 9 Year: 2011 Page: 871-876
Author(s): Klaus G. Parhofer
Sobetirome: A Selective Thyromimetic for the Treatment of Dyslipidemia
Journal: Recent Patents on Cardiovascular Drug Discovery (Discontinued)
Volume: 6 Issue: 1 Year: 2011 Page: 16-19
Author(s): Ivan Tancevski, Egon Demetz, Philipp Eller
Enhanced Proinflammatory State and Autoimmune Activation: a Breakthrough to Understanding Chronic Diseases
Journal: Current Pharmaceutical Design
Volume: 20 Issue: 4 Year: 2014 Page: 575-584
Author(s): Altan Onat,Gunay Can
Lipoprotein(a): Current Perspectives
Journal: Current Vascular Pharmacology
Volume: 9 Issue: 6 Year: 2011 Page: 682-692
Author(s): Ioanna Gouni-Berthold, Heiner K. Berthold
Lipoprotein(a) Management: Pharmacological and Apheretic Treatment
Journal: Current Medicinal Chemistry
Volume: 24 Issue: 10 Year: 2017 Page: 957-968
Author(s): Ruth Hanssen,Ioanna Gouni-Berthold
Emerging Targets for the Treatment of Dyslipidemia
Journal: Current Medicinal Chemistry
Volume: 18 Issue: 6 Year: 2011 Page: 909-922
Author(s): A. Tavridou, G. Ragia, V. G. Manolopoulos
PCSK9 Biomarker and Key Modulator for Cardiovascular Disorders:Heralding a New Therapeutic Era and Their Future Perspectives
Journal: Current Molecular Pharmacology
Volume: 16 Issue: 8 Year: 2023 Page: 832-854
Author(s):
Apolipoprotein B Antisense Inhibition -Update on Mipomersen
Journal: Current Pharmaceutical Design
Volume: 19 Issue: 1 Year: 2013 Page: 3132-3142
Author(s): Catherine Gebhard, Gabriel Huard, Ekaterini A. Kritikou, Jean-Claude Tardif
Combined Dyslipidemia: Should the Focus be LDL Cholesterol or Atherogenic Dyslipidemia?
Journal: Current Pharmaceutical Design
Volume: 19 Issue: 2 Year: 2013 Page: 3858-3868
Author(s): Manfredi Rizzo, Marcin Barylski, Ali A. Rizvi, Giuseppe Montalto, Dimitri P. Mikhailidis, Maciej Banach